These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4902056)

  • 21. Serum levels and urinary excretion of chloramphenicol in the presence of isoniazid and salicylate.
    Mattila MJ; Takki S; Heino AE
    Ann Med Exp Biol Fenn; 1969; 47(3):203-8. PubMed ID: 5367516
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood concentration of chloramphenicol in horses after intramuscular or oral administration.
    Oishi S
    Nihon Juigaku Zasshi; 1968 Feb; 30(1):25-8. PubMed ID: 5692325
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biliary excretion of chloramphenicol. 3. Intramuscular administration of suspensions of various brands].
    Havelka J
    Cas Lek Cesk; 1973; 112(28):856-9. PubMed ID: 4720440
    [No Abstract]   [Full Text] [Related]  

  • 24. [Problems in the rectal use of chloramphenicol].
    Briedigkeit W; Göres E; Schneeweiss B; Wachholz E; Wiegand U
    Padiatr Grenzgeb; 1972; 11(4):241-51. PubMed ID: 4662526
    [No Abstract]   [Full Text] [Related]  

  • 25. Biliary chloramphenicol excretion. 3. Following intramuscular administration of suspensions of different provenance.
    Havelka J
    Rev Czech Med; 1973; 19(1):39-46. PubMed ID: 4693323
    [No Abstract]   [Full Text] [Related]  

  • 26. Concentration of chloramphenicol in the urine and blood in relation to renal function.
    Lindberg AA; Nilsson LH; Bucht H; Kallings LO
    Br Med J; 1966 Sep; 2(5516):724-8. PubMed ID: 5917389
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of chloramphenicol metabolites and some factors affecting metabolic disposition.
    Glazko AJ
    Antimicrob Agents Chemother (Bethesda); 1966; 6():655-65. PubMed ID: 5985304
    [No Abstract]   [Full Text] [Related]  

  • 28. Steady state of chloramphenicol in malnourished children.
    Mehta S; Nain CK; Sharma B; Mathur VS
    Indian J Med Res; 1981 Apr; 73():538-42. PubMed ID: 7262924
    [No Abstract]   [Full Text] [Related]  

  • 29. Chloramphenicol blood concentration studies in dogs.
    Mercer HD; Geleta JN; Kramer J; Carter G
    J Am Vet Med Assoc; 1971 Jan; 158(1):47-52. PubMed ID: 5545329
    [No Abstract]   [Full Text] [Related]  

  • 30. The particle size evaluation of parenteral suspensions of chloramphenicol and correlation of particle size to plasma levels.
    Kitamori N; Kawajiri S; Matsuzawa T
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2597-602. PubMed ID: 1017098
    [No Abstract]   [Full Text] [Related]  

  • 31. [Investigation of the absorption of orally administered chloramphenicol preparations].
    Finholt P; Lunde PK; Midtvedt T; Aarnes ED
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1245-6. PubMed ID: 5565809
    [No Abstract]   [Full Text] [Related]  

  • 32. [Suspensions of chloramphenicol palmitate. Enzymatic hydrolysis and resorption].
    Dony J; De Roeck A
    J Pharm Belg; 1965; 20(11):475-83. PubMed ID: 5864900
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma chloramphenicol levels in dogs after the administration of four different oral preparations of chloramphenicol.
    Watson AD
    Aust Vet J; 1973 Oct; 49(10):460-2. PubMed ID: 4774387
    [No Abstract]   [Full Text] [Related]  

  • 34. Chloromycetin palmitate; observations on absorption, blood serum levels, and urinary excretion.
    YOW EM; TAYLOR FM; HIRSCH J; FRANKEL RA; CARNES HE
    J Pediatr; 1953 Feb; 42(2):151-6. PubMed ID: 13023513
    [No Abstract]   [Full Text] [Related]  

  • 35. [Excretion of chloramphenicol in the milk after oral and parenteral administration in lactating cows].
    De Corte-Baeten K; Debackere M
    Dtsch Tierarztl Wochenschr; 1976 May; 83(5):231-3. PubMed ID: 776570
    [No Abstract]   [Full Text] [Related]  

  • 36. [Kinetics of the absorption of D-chloramphenicol following its peroral and intramuscular administration].
    Nadvornikova G; Grafnetterova I; Shiuk O
    Antibiotiki; 1974 Dec; 19(12):1068-73. PubMed ID: 4447345
    [No Abstract]   [Full Text] [Related]  

  • 37. [Distribution of chloramphenicol in experimental pyelonephritis].
    Grafnetterová J; Hatala M; Prát V
    Cas Lek Cesk; 1969 Jan; 108(4):117-21. PubMed ID: 4888780
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic absorption of topically applied chloramphenicol eyedrops.
    Trope GE; Lawrence JR; Hind VM; Bunney J
    Br J Ophthalmol; 1979 Oct; 63(10):690-1. PubMed ID: 508680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous use of chlorocide (chloramphenicol) succinate sodium. Clinical observations and laboratory assays.
    Biró L; Iván E; Lévai O
    Ther Hung; 1971; 19(4):142-7. PubMed ID: 4947682
    [No Abstract]   [Full Text] [Related]  

  • 40. Special characteristics of absorption and excretion of chloramphenicol in premature and newborn infants.
    Nishimura T; Kotani Y
    Bull Osaka Med Sch; 1970 Oct; 16(2):169-81. PubMed ID: 5511545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.